Management of atrial fibrillation in COVID-19 pandemic

Yu Feng Hu, Wen Han Cheng, Yuan Hung, Wen Yu Lin, Tze Fan Chao, Jo Nan Liao, Yenn Jiang Lin, Wei Shiang Lin, Yi Jen Chen, Shih Ann Chen

Research output: Contribution to journalReview articlepeer-review

18 Citations (Scopus)


The health crisis due to coronavirus disease 2019 (COVID-19) has shocked the world, with more than 1 million infections and casualties. COVID-19 can present from mild illness to multi-organ involvement, but especially acute respiratory distress syndrome. Cardiac injury and arrhythmias, including atrial fibrillation (AF), are not uncommon in COVID-19. COVID-19 is highly contagious, and therapy against the virus remains premature and largely unknown, which makes the management of AF patients during the pandemic particularly challenging. We describe a possible pathophysiological link between COVID-19 and AF, and therapeutic considerations for AF patients during this pandemic.

Original languageEnglish
Pages (from-to)1679-1685
Number of pages7
JournalCirculation Journal
Issue number10
Publication statusPublished - Sept 25 2020


  • Ablation
  • Antiarrhythmic drugs
  • Atrial fibrillation
  • Oral anticoagulation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Management of atrial fibrillation in COVID-19 pandemic'. Together they form a unique fingerprint.

Cite this